|
|
|
|
| LEADER |
007600000a22002170004500 |
| 020 |
|
|
|a 978-0-8493-8796-8
|
| 082 |
|
|
|a 615.31 P8
|
| 100 |
|
|
|a Crooke, Stanley T; Editor
|
| 245 |
|
|
|a Antisense drug technology: principles, strategies and applications
|
| 250 |
|
|
|a 2nd ed
|
| 260 |
|
|
|a London, CRC Press
|e 2007
|
| 260 |
|
|
|c 2008
|
| 460 |
|
|
|a xvii, 825p
|
| 465 |
|
|
|a GBP125.00
|
| 500 |
|
|
|a ed by Stanley T Crooke
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 650 |
|
|
|a Antisense nucleic acids-Therapeutic use
|
| 650 |
|
|
|a Oligonucleotides, Antisense-Therapeutic use
|
| 942 |
|
|
|c BK
|
| 999 |
|
|
|c 47554
|d 47554
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_310000000000000_P8
|7 0
|8 ENG
|9 48286
|a MGUL
|b MGUL
|d 2013-07-16
|e GBP125.00
|l 0
|o 615.31 P8
|p 45803
|r 2013-07-16
|w 2013-07-16
|y BK
|